Table 3.

Procedural and in-hospital details.

	Baseline no RVD		Baseline RVD		p-value
	No RVD (n = 325)	New-onset RVD (n = 106)	Normalized RVD (n = 73)	Residual RVD (n = 94)	All groups
Procedural details
Procedure time, min	112.0 (81.0–147.0)	107.0 (85.0–143.0)	102.0 (84.0–133.0)	107.0 (84.0–151.0)	0.623
Fluoroscopy time, min	8.4 (5.9–11.2)	8.1 (6.2–11.3)	7.7 (6.2–10.5)	8.2 (6.2–12.1)	0.863
Contrast medium volume, ml	627.0 (572.0–686.0)	616.0 (554.0–711.0)	600.0 (554.0–686.0)	616.0 (554.0–736.0)	0.527
Device success	96.9 (315)	93.4 (99)	94.5 (69)	95.7 (90)	0.344
Conversion to an operation	1.2 (4)	2.8 (3)	4.1 (3)	2.1 (2)	0.259
Coronary obstruction	0.6 (2)	2.8 (3)	1.4 (1)	0 (0)	0.127
Aortic root injury	1.5 (5)	1.9 (2)	1.4 (1)	2.1 (2)	0.925
Valve-in-valve	0.6 (2)	0 (0)	0 (0)	0 (0)	1.000
New permanent pacemaker	9.5 (31)	10.4 (11)	4.1 (3)	7.4 (7)	0.426
In-hospital details
Myocardial infarction	0.3 (1)	1.0 (1)	1.4 (1)	1.1 (1)	0.267
Stroke	0.9 (3)	0 (0)	0 (0)	0 (0)	1.000
Life-threatening or major bleeding	0 (0)	1.0 (1)	1.4 (1)	1.1 (1)	0.091
Major vascular complication	0.9 (3)	1.0 (1)	0 (0)	1.1 (1)	1.000
Pacemaker implanted in-hospital	6.2 (20)	11.8 (12)	5.7 (4)	16.3 (15)	0.011
Acute kidney injury	7.8 (25)	6.9 (7)	10.0 (7)	14.1 (13)	0.235
Duration between procedures and TTE reassessment	5.5 (3.0–7.0)	6.0 (4.0–7.0)	7.0 (5.0–9.0)	6.5 (4.0–8.0)	0.418
Aortic regurgitation ≥ moderate	0.9 (3)	0 (0)	2.9 (2)	1.1 (1)	0.273
Mitral regurgitation ≥ moderate	19.3 (62)	28.4 (29)	37.1 (26)	31.5 (29)	0.003
Length of hospital stay, days	10.0 (7.0–13.0)	10.0 (7.0–12.0)	14.5 (8.0–19.0)	13.5 (8.0–19.0)	<0.001

RVD, right ventricular dysfunction; TTE, transthoracic echocardiography.

The bold p value means that the value is <0.05.